SEM — Select Medical Holdings Corporation stock price, charts and financials
QT49Select Medical Holdings CorporationSelect Medical Holdings Corporation (NYSE: SEM) is a Healthcare company in the Medical - Care Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 15.15 | EPS (ttm) | 1.09 | Insider Own | 17.83% | Shs Outstand | 123.94M | Perf Week | -0.30% |
| Market Cap | 2.05B | Forward P/E | 12.35 | EPS next Y | 1.34 | Insider Trans | 0.00% | Shs Float | 97.34M | Perf Month | 0.06% |
| Enterprise Value | 4.83B | PEG | 2.70 | EPS next Q | - | Inst Own | - | Short Float | 1.19% | Perf Quarter | 1.35% |
| Income | 134.00M | P/S | 0.37 | EPS this Y | 11.94% | Inst Trans | - | Short Ratio | 0.51 | Perf Half Y | 11.78% |
| Sales | 5.52B | P/B | 0.97 | EPS next Y | 9.55% | ROA | 2.21% | Short Interest | 1.15M | Perf YTD | 11.18% |
| Book/sh | 16.99 | P/C | 78.69 | EPS next 5Y | 5.62% | ROE | 7.83% | 52W High | 16.99 -2.83% | Perf Year | 8.12% |
| Cash/sh | 0.21 | P/FCF | 17.45 | EPS past 3/5Y | -1.37% -9.37% | ROIC | 4.78% | 52W Low | 11.65 41.72% | Perf 3Y | 4.10% |
| Dividend Est. | 0.25 (1.51%) | EV/EBITDA | 9.33 | Sales past 3/5Y | -4.87% -0.29% | Gross Margin | 10.65% | Volatility | 0.34% 0.38% | Perf 5Y | -26.52% |
| Dividend TTM | 0.25 (1.51%) | EV/Sales | 0.88 | EPS Y/Y TTM | -34.34% | Oper. Margin | 5.83% | ATR (14) | 0.06 | Perf 10Y | 177.01% |
| Dividend Ex-Date | May 14, 2026 | Quick Ratio | 1.15 | Sales Y/Y TTM | 6.44% | Profit Margin | 2.42% | RSI (14) | 45.87 | Recom | 2.71 |
| Dividend Gr. 3/5Y | -2.45% - | Current Ratio | 1.15 | EPS Q/Q | -18.18% | SMA20 | -0.32% | Beta | 0.99 | Target Price | 17.75 |
| Payout | 23.54% | Debt/Eq | 1.82 | Sales Q/Q | 5.03% | SMA50 | 0.03% | Rel Volume | 12.32 | Prev Close | 16.53 |
| Employees | 45,300 | LT Debt/Eq | 1.71 | Earnings | Jul 30 | SMA200 | 8.51% | Avg Volume | 2.26M | Price | 16.51 |
| IPO Date | Sep 25, 2009 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -21.01% 0.74% | Net Debt/EBITDA | 5.72 | Volume | 27,813,219 | Change | -0.12% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| May-13-26 | Downgrade | Mizuho | Outperform → Neutral | $17 |
| Mar-04-26 | Downgrade | Benchmark | Buy → Hold | |
| Mar-03-26 | Downgrade | RBC Capital | Outperform → Sector Perform | |
| Feb-23-26 | Reiterated | RBC Capital | Outperform | $20 → $19 |
| Nov-03-25 | Reiterated | Mizuho Securities | $17 | |
| Oct-08-25 | Reiterated | RBC Capital | Outperform | $40 → $20 |
| Aug-04-25 | Reiterated | UBS | Neutral | $14 |
| Nov-25-24 | Downgrade | Benchmark | Buy → Hold | |
| May-06-24 | Reiterated | RBC Capital | Outperform | $40 |
| Jun-16-20 | Downgrade | B of A Securities | Neutral → Underperform |
Select Medical Holdings Corporation (SEM) is a U.S.-based healthcare organization that manages a diverse portfolio of specialized medical facilities. The company operates across four primary divisions: critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers. Its Critical Illness Recovery Hospital division focuses on patients with severe and complex medical conditions, such as heart failure, infectious diseases, respiratory failure, renal issues, neurological events, and trauma requiring extended recovery. The Rehabilitation Hospital division delivers therapeutic and rehabilitative care for conditions including brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic challenges, pediatric disabilities, and cancer. The Outpatient Rehabilitation division comprises clinics offering physical, occupational, and speech therapy, alongside specialized programs for work-related injuries, hand therapy, post-concussion recovery, pediatric and cancer rehabilitation, and athletic training. Lastly, the Concentra division provides occupational medicine, consumer health, physical therapy, and wellness services through its occupational health centers and contract services located at employer worksites. As of December 31, 2021, Select Medical's extensive network included 104 critical illness recovery hospitals spanning 28 states, 30 rehabilitation hospitals across 12 states, 1,881 outpatient rehabilitation clinics in 38 states and D.C., 518 occupational health centers in 41 states, and 134 on-site clinics at employer locations. Founded in 1996, the company maintains its headquarters in Mechanicsburg, Pennsylvania.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5,521 | 5,453 | 5,187 | 6,664 | 6,334 | 6,205 | 5,532 | 5,454 | 5,081 | |
| Cost of Goods Sold Incl. D&A | 4,933 | 4,824 | 4,553 | 5,732 | 5,600 | 5,285 | 4,710 | 4,641 | 4,341 | |
| Gross Profit | 587 | 629 | 634 | 932 | 733 | 919 | 821 | 813 | 740 | |
| Selling, General and Administrative Excl. Other | 161 | 154 | 226 | 170 | 153 | 147 | 138 | 128 | 121 | |
| Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other Operating Expense | 105 | 141 | 139 | 207 | 177 | 59 | 116 | 213 | 202 | |
| Operating Income | 322 | 335 | 268 | 555 | 403 | 714 | 568 | 472 | 417 | |
| Interest Expense | 117 | 118 | 129 | 199 | 169 | 136 | 153 | 201 | 198 | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 54 | 56 | 35 | 26 | 26 | 52 | 42 | -7 | 17 | |
| Net Income Before Taxes | 258 | 273 | 175 | 382 | 261 | 630 | 456 | 265 | 236 | |
| Income Taxes | 55 | 58 | 45 | 83 | 63 | 130 | 112 | 64 | 59 | |
| Consolidated Net Income | 134 | 146 | 214 | 243 | 159 | 402 | 259 | 148 | 138 | |
| Net Income From Continuing Operations | 204 | 215 | 130 | 300 | 198 | 500 | 345 | 201 | 177 | |
| Net Income | 134 | 146 | 214 | 243 | 159 | 402 | 259 | 148 | 138 | |
| EPS (Recurring) | 1.09 | 1.18 | 1.66 | 1.91 | 1.23 | 2.99 | 1.93 | 1.54 | 1.06 | |
| EPS (Basic, Before Extraordinaries) | 1.09 | 1.18 | 1.66 | 1.91 | 1.23 | 2.99 | 1.93 | 1.54 | 1.06 | |
| EPS (Diluted) | 1.09 | 1.18 | 1.66 | 1.91 | 1.23 | 2.99 | 1.93 | 1.54 | 1.06 | |
| EBITDA | 518 | 531 | 507 | 790 | 636 | 968 | 683 | 678 | 622 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 15.15 | 12.58 | 11.36 | 6.63 | 10.87 | 5.29 | 7.72 | 8.16 | 7.80 | |
| Price To Sales Ratio | 0.37 | 0.34 | 0.47 | 0.23 | 0.26 | 0.33 | 0.35 | 0.30 | 0.21 | |
| Gross Margin | 10.63 | 11.53 | 12.22 | 13.99 | 11.57 | 14.81 | 14.84 | 14.91 | 14.56 | |
| Operating Margin | 5.83 | 6.14 | 5.17 | 8.33 | 6.36 | 11.51 | 10.27 | 8.65 | 8.21 | |
| Net Margin | 2.43 | 2.68 | 4.13 | 3.65 | 2.51 | 6.48 | 4.68 | 2.71 | 2.72 | |
| Shares Outstanding | 124 | 124 | 129 | 123 | 125 | 130 | 130 | 130 | 130 | |
| Market Capitalization | 2,047 | 1,841 | 2,432 | 1,557 | 1,671 | 2,058 | 1,937 | 1,634 | 1,075 | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Khanuja Parvinderjit S. | Director | May 05 '25 | Buy | 15.02 | 21,000 | 315,420 | 65,089 | May 06 |
| CHERNOW DAVID S | CEO | Apr 28 '25 | Sale | 18.00 | 225,000 | 4,050,000 | 714,516 | Apr 29 |
| Breighner Robert G. JR | VICE PRESIDENT, COMPLIANCE | Dec 04 '24 | Sale | 19.95 | 4,989 | 99,531 | 30,356 | Dec 06 |
| ORTENZIO ROBERT A | EXECUTIVE CHAIRMAN | Nov 26 '24 | Sale | 19.55 | 3,804,805 | 74,383,938 | 0 | Nov 29 |
| TAVENNER MARILYN B | Director | Nov 26 '24 | Sale | 21.09 | 32,000 | 674,880 | 22,000 | Nov 29 |
| ORTENZIO ROBERT A | EXECUTIVE CHAIRMAN | Apr 08 '24 | Sale | 29.90 | 50,000 | 1,495,000 | 6,689,668 | Apr 10 |
| ORTENZIO ROBERT A | EXECUTIVE CHAIRMAN | Mar 08 '24 | Sale | 28.30 | 50,000 | 1,415,000 | 6,739,668 | Mar 11 |
| ORTENZIO ROBERT A | EXECUTIVE CHAIRMAN | Feb 08 '24 | Sale | 26.00 | 50,000 | 1,300,000 | 6,789,668 | Feb 09 |
| ORTENZIO ROBERT A | EXECUTIVE CHAIRMAN | Jan 08 '24 | Sale | 26.63 | 100,000 | 2,663,000 | 6,839,668 | Jan 09 |
| ORTENZIO ROBERT A | EXECUTIVE CHAIRMAN | Dec 14 '23 | Sale | 25.00 | 100,000 | 2,500,000 | 6,939,668 | Dec 14 |
| ORTENZIO ROBERT A | EXECUTIVE CHAIRMAN | Sep 08 '23 | Sale | 26.82 | 50,000 | 1,341,000 | 7,039,668 | Sep 11 |
| ORTENZIO ROBERT A | EXECUTIVE CHAIRMAN | Aug 08 '23 | Sale | 29.52 | 50,000 | 1,476,000 | 7,089,668 | Aug 09 |
| ORTENZIO ROBERT A | EXECUTIVE CHAIRMAN | Jul 10 '23 | Sale | 30.36 | 50,000 | 1,518,000 | 6,889,668 | Jul 11 |
| ORTENZIO ROBERT A | EXECUTIVE CHAIRMAN | Jun 29 '23 | Sale | 32.00 | 100,000 | 3,200,000 | 1,279,000 | Jun 30 |
| ORTENZIO ROBERT A | EXECUTIVE CHAIRMAN | Jun 21 '23 | Sale | 30.00 | 33,967 | 1,019,010 | 1,379,000 | Jun 22 |